Providence Cancer Center offered this state-of-the-art symposium to lung cancer specialists in the Pacific Northwest on November 17, 2007.
The most recent technological advances in pulmonology, thoracic surgery, interventional pulmonology and radiation oncology were presented by internationally renowned physicians who share The Thoracic Oncology Program's dedication to advancing state-of-the-art care for lung cancer patients nationwide.
Follow the links below to view the symposium presentations in their entirety.
These files are best viewed with a high-speed internet connection. Download times may vary. Streaming video files require WindowsMedia Viewer. For best clarity, minimize the window for streaming video. Please call the Thoracic Oncology Program at 503-215-6724 for further information.
This program was made possible through educational grants from Sanofi-Aventis, OSI Pharmaceuticals, Inc.; Genentech; Eli Lilly; Onyx-Pharmaceuticals, GlaxoSmithKline; and Bayer Healthcare.
Peter Mazzone, MD, M.P.H.
The Cleveland Clinic
Preoperative Evaluation for Lung Cancer
The literature that guides decisions regarding fitness for lung resection
Guidelines that are based on the lung resection literature
The means available to optimize the outcome of a patient undergoing lung resection
Alternatives to conventional resection
Dr. Mazzone is the director of the Lung Cancer Program for the Department of Pulmonary, Allergy, and Critical Care Medicine at the Cleveland Clinic.
John R. Handy, Jr., MD
Co-director, Providence Thoracic Oncology Program
Director, Providence Thoracic Surgery Program
Thoracic Surgeon, The Oregon Clinic
Outcomes in the Marginal Lung Cancer Surgery Patient
Surgical risk assessment in preparation for lung surgery
The important outcomes of lung cancer surgery
The outcomes of lung cancer surgery, especially regarding the marginal patient
Dr. Handy has a special interest in cancers of the chest, with an emphasis on advanced surgical techniques. He has specialized expertise in minimally invasive surgery.
Alex Gottschalk, M.D., Ph.D. University of California, San Francisco
Stereotactic Radiosurgery for Lung Cancer
What is stereotactic radiosurgery?
Local control and overall survival with convention radiation
Published results and toxicity of stereotactic radiosurgery for early stage lung cancer
A comparison of doses delivered using conventional radiation versus stereotactic radiosurgery
Dr. Gottschalk is Assistant Professor in Residence, Step 3, Department of Radiation Oncology School of Medicine at University of California, San Francisco.
John R. Handy, Jr., MD
Co-director, Providence Thoracic Oncology Program
Director, Providence Thoracic Surgery Program
Thoracic Surgeon, The Oregon Clinic
Providence Thoracic Oncology Program as a Regional Resource
In his role as the medical director of Providence Thoracic Surgery Program and the co-medical director of Providence Thoracic Oncology Program, Dr. Handy has led efforts to develop national and institution-based protocols to improve patient selection guidelines and treatment outcomes.
Steven Seung, M.D., Ph.D. Gamma Knife Center of Oregon Radiation Oncologist, The Oregon Clinic
Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy
Effect of high dose radiation on tumor cells and its immunogenicity
SBRT and its potential implications for immunotherapy
Future plans for SBRT/immunotherapy at Earle A. Chiles Research Center
Dr. Seung earned his Ph.D. and medical degree from the University of Chicago. He completed his residency in radiation oncology at the University of California - San Francisco, where he also received his Gamma Knife training. Board certified in radiation oncology, Dr. Seung practices with The Oregon Clinic and is director of the Gamma Knife Center of Oregon.
Return to